$TTNP·4

TITAN PHARMACEUTICALS INC · Oct 14, 12:09 PM ET

TITAN PHARMACEUTICALS INC 4

4 · TITAN PHARMACEUTICALS INC · Filed Oct 14, 2014

Insider Transaction Report

Form 4
Period: 2014-10-09
BHONSLE SUNIL
DirectorPresident
Transactions
  • Purchase

    Common Stock

    2014-10-10$0.49/sh+24,000$11,6880 total
  • Purchase

    Common Stock

    2014-10-09$0.48/sh+100,000$47,8000 total
  • Purchase

    Common Stock

    2014-10-13$0.47/sh+92,000$43,240356,500 total
Holdings
  • Common Stock

    (indirect: By Trust)
    300,757
Footnotes (4)
  • [F1]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.468 to $0.49. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.463 to $0.485. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F3]Does not include 10,000 shares held by his adult son.
  • [F4]The reporting person is the trustee of the family trust owning the indicated shares.

Documents

1 file
  • 4
    v391244_form4.xmlPrimary

    FORM 4